Literature DB >> 2306186

Achievements of physical therapy in patients after modified radical mastectomy compared with quadrantectomy, axillary dissection, and radiation for carcinoma of the breast.

H Gutman1, T Kersz, T Barzilai, M Haddad, R Reiss.   

Abstract

Flexion of the shoulder, abduction, and external rotation in 90 degrees abduction are impaired after operations for breast cancer. We compared postoperative range of motion in 27 patients who underwent modified radical mastectomy and 21 patients who underwent quadrantectomy with axillary dissection and radiation therapy. The patients in the quadrantectomy group demonstrated a significantly higher range of flexion on postoperative day 1 and the day of suture removal. After 3 months, all patients had regained their preoperative range of flexion, with no difference between the groups. The better compliance of the quadrantectomy group to physical therapy may indicate that they suffer less pain and require a briefer or less intensive course of physical therapy.

Entities:  

Mesh:

Year:  1990        PMID: 2306186     DOI: 10.1001/archsurg.1990.01410150111020

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

1.  Low incidence of lymph node metastasis in patients with microinvasive breast cancer: a Korean nationwide study.

Authors:  Pill Sun Paik; Nam Sun Paik; Eun Sook Lee; Jung Eun Choi; Joon Jeong; Hyun Jo Youn; Chang Ik Yoon; Soo Youn Bae; Tae-Kyung Yoo
Journal:  Ann Surg Treat Res       Date:  2022-06-07       Impact factor: 1.766

2.  Pre-operative assessment enables early diagnosis and recovery of shoulder function in patients with breast cancer.

Authors:  Barbara A Springer; Ellen Levy; Charles McGarvey; Lucinda A Pfalzer; Nicole L Stout; Lynn H Gerber; Peter W Soballe; Jerome Danoff
Journal:  Breast Cancer Res Treat       Date:  2010-02       Impact factor: 4.872

3.  Primary tumour characteristics and axillary lymph node status in breast cancer.

Authors:  C Yiangou; S Shousha; H D Sinnett
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.